SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-224391
Filing Date
2008-11-04
Accepted
2008-11-04 17:01:38
Documents
7
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 331616
2 RESEARCH AND LICENSE AGREEMENT DATED AS OF JULY 2, 2008 dex101.htm EX-10.1 215013
3 LETTER AGREEMENT DATED JULY 2, 2008 dex102.htm EX-10.2 19384
4 RULE 13A - 14(A) CERTIFICATION BY PRESIDENT AND CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8815
5 RULE 13A - 14(A) CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER dex312.htm EX-31.2 8984
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3361
7 GRAPHIC g65442g71d83.jpg GRAPHIC 5940
  Complete submission text file 0001193125-08-224391.txt   596942
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 081161508
SIC: 2836 Biological Products, (No Diagnostic Substances)